Laser device company Chromogenex lists on London's AIM (Alternative Investment Market), raises pounds2m:
This article was originally published in Clinica
Executive Summary
Chromogenex, the UK medical and aesthetic laser device company formerly known as EUPhotonics, has listed on London's Alternative Investment Market (AIM). The company raised £2m ($3.6m), and floated with a market capitalisation of £6.51m. Its main products are the Chromolite intense pulsed light treatment for removing hair, skin pigmentation and thread veins, and the Nlite pulsed-dye laser system for vascular lesions, acne and psoriasis.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.